{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T21:23:16Z","timestamp":1747948996200},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatitis C virus (HCV) is estimated to infect 200 million individuals in the globe, including approximately 10 million in Pakistan causing both acute and chronic hepatitis. The standard treatment against HCV is pegylated interferon therapy in combination with a nucleoside analogue ribavirin. In addition, several herbal extracts and phytochemicals derivatives are used traditionally in the treatment of liver diseases as well as HCV infection. The present study determines the inhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell lines<jats:bold>.<\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Huh-7 cell lines were used for the <jats:italic>in vitro<\/jats:italic> HCV replication by using HCV positive sera from different patients with known HCV genotypes and viral titer\/load. Total RNA was extracted from these infected cells and was quantified by real-time polymerase chain reaction (Real-time PCR). The viral titer was compared with the control samples to determine the anti-HCV activity of kaolin derived compounds. Kaolin is a group of clay minerals, with the chemical composition Al<jats:sub>2<\/jats:sub> Si<jats:sub>2<\/jats:sub>O<jats:sub>5<\/jats:sub> (OH)<jats:sub>4<\/jats:sub>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results showed promising effectiveness of local kaolin derived anti-HCV compounds by causing 28% to 77% decrease in the HCV titer, when applied to infected Huh-7 cell lines. This study provides the basis for future work on these compounds especially to determine the specific pathway and mechanism for inhibitory action in the replicon systems of viral hepatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Kaolin mineral derivatives show promising inhibitory effects against HCV genotypes 3a and 1a infection, which suggests its possible use as complementary and alternative medicine for HCV viral infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-7-247","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T17:49:31Z","timestamp":1397756971000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell lines"],"prefix":"10.1186","volume":"7","author":[{"given":"Liaqat","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irshad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Abbas","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad Hassan","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,17]]},"reference":[{"key":"2765_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2000-9506","volume":"20","author":"A Wasley","year":"2000","unstructured":"Wasley A, Alter MJ: Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000, 20: 1-16. 10.1055\/s-2000-9506.","journal-title":"Semin Liver Dis"},{"key":"2765_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1479-0556-9-2","volume":"9","author":"I Rehman","year":"2011","unstructured":"Rehman I, Idrees M, Ali M, Ali L, Butt S, Hussain A, Akbar H, Afzal S: Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan. Genet Vaccines Ther. 2011, 9: 2-10.1186\/1479-0556-9-2.","journal-title":"Genet Vaccines Ther"},{"key":"2765_CR3","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1038\/sj.cdd.4401121","volume":"10","author":"C Giannini","year":"2003","unstructured":"Giannini C, Brechot C: Hepatitis C virus biology. Cell Death Differ. 2003, 10: S27-38. 10.1038\/sj.cdd.4401121.","journal-title":"Cell Death Differ"},{"key":"2765_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2006, 5: 558-567.","journal-title":"Lancet Infect Dis"},{"key":"2765_CR5","first-page":"012","volume":"1","author":"H Akbar","year":"2009","unstructured":"Akbar H, Idrees M, Manzoor S, Rehman IU, Butt S, Yousaf MZ, Rafique S, Awan Z, Khubaib B, Akram M, Aftab M: Hepatitis C virus infection: A review of the current and future aspects and concerns in Pakistan. JGMV. 2009, 1: 012-018.","journal-title":"JGMV"},{"key":"2765_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1743-422X-3-98","volume":"3","author":"SL Lederer","year":"2006","unstructured":"Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, Boix L, Fausto N: Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J. 2006, 3: 98-10.1186\/1743-422X-3-98.","journal-title":"Virol J"},{"key":"2765_CR7","first-page":"1420","volume":"48","author":"K Miura","year":"2008","unstructured":"Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA: Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Viral Hepatitis. 2008, 48: 1420-1429.","journal-title":"Viral Hepatitis"},{"issue":"2","key":"2765_CR8","doi-asserted-by":"publisher","first-page":"e1000291","DOI":"10.1371\/journal.ppat.1000291","volume":"5","author":"MA Joyce","year":"2009","unstructured":"Joyce MA, Walters KA, Lamb SE, Yeh MM, Zhu LF, Kneteman N, Doyle JS, Katze MG, Tyrrell DL: HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID\/Alb-uPA Mice. PLoS Pathog. 2009, 5 (2): e1000291-10.1371\/journal.ppat.1000291.","journal-title":"PLoS Pathog"},{"key":"2765_CR9","doi-asserted-by":"publisher","first-page":"e1000269","DOI":"10.1371\/journal.ppat.1000269","volume":"5","author":"KA Walters","year":"2009","unstructured":"Walters KA, Syder AJ, Lederer SL, Diamond DL, Paeper B, Rice CM, Katze MG: Genomic analysis revealsb a potential role for cell cycle perturbation in HCV mediated apoptosis of cultured hepatocytes. Plos pathogens. 2009, 5: e1000269-10.1371\/journal.ppat.1000269.","journal-title":"Plos pathogens"},{"key":"2765_CR10","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3748\/wjg.15.5080","volume":"15","author":"M Idrees","year":"2009","unstructured":"Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, Butt S, Awan Z, Manzoor S, Akram M, Aftab M, Khubaib B, Riazuddin S: Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World J Gastroenterol. 2009, 15: 5080-5085. 10.3748\/wjg.15.5080.","journal-title":"World J Gastroenterol"},{"key":"2765_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2036.2004.02170.x","volume":"20","author":"GR Foster","year":"2004","unstructured":"Foster GR: Pegylated interferons: Chemical and Clinical Differences. Aliment Pharmacol Ther. 2004, 20: 825-30. 10.1111\/j.1365-2036.2004.02170.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"2765_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1743-422X-8-71","volume":"8","author":"S Afzal","year":"2011","unstructured":"Afzal S, Idrees M, Ali M, Ilyas M, Hussain A, Akram M, Butt S, Rehman I, Ali L, Shahid M: Envelope 2 protein phosphorrylat-ion sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approach. Virol J. 2011, 8: 71-10.1186\/1743-422X-8-71.","journal-title":"Virol J"},{"key":"2765_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347: 975-82. 10.1056\/NEJMoa020047.","journal-title":"N Engl J Med"},{"key":"2765_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peg interferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001, 358: 958-65. 10.1016\/S0140-6736(01)06102-5.","journal-title":"Lancet"},{"key":"2765_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature04082","volume":"436","author":"JJ Feld","year":"2005","unstructured":"Feld JJ, Hoofnagle JH: Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005, 436: 967-972. 10.1038\/nature04082.","journal-title":"Nature"},{"key":"2765_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-422X-8-26","volume":"8","author":"T Javed","year":"2011","unstructured":"Javed T, Ashfaq UA, Riaz S, Rehman S, Riazuddin S: In-vitro antiviral activity of Solanum nigrum against activity Hepatitis C Virus. Virol J. 2011, 8: 26-10.1186\/1743-422X-8-26.","journal-title":"Virol J"},{"key":"2765_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0166-3542(97)00069-7","volume":"37","author":"K Kitamura","year":"1998","unstructured":"Kitamura K, Honda M, Youshizaki H: Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res. 1998, 37: 131-140. 10.1016\/S0166-3542(97)00069-7.","journal-title":"Antiviral Res"},{"key":"2765_CR18","volume-title":"An introduction to the rock-forming minerals","author":"WA Deer","year":"1992","unstructured":"Deer WA, Howie RA, Zussman J: An introduction to the rock-forming minerals. 1992, Harlow: Longman, ISBN 0582300940, 2","edition":"2"},{"key":"2765_CR19","first-page":"31","volume":"10","author":"W Yu","year":"1995","unstructured":"Yu W, Foster HD, Zhang T: Discovering Chinese Mineral Drugs. J Orthomol Med. 1995, 10: 31-58.","journal-title":"J Orthomol Med"},{"key":"2765_CR20","volume-title":"Identification of Chinese Mineral Medicines","author":"SN Yang","year":"1990","unstructured":"Yang SN: Identification of Chinese Mineral Medicines. 1990, Shanghai: Shanghai Scientific Literature Publishing House"},{"issue":"2","key":"2765_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12011-013-9617-8","volume":"152","author":"NF Kolachi","year":"2013","unstructured":"Kolachi NF, Kazi TG, Afridi HI, Kazi NG, Mughal MA, Khan S: Effects of selenium and zinc status in biological samples of hepatitis C patient after herbal and pharmaceutical supplements. Biol Trace Elem Res. 2013, 152 (2): 187-94. 10.1007\/s12011-013-9617-8.","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"2765_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2307\/3242964","volume":"87","author":"A Alpert","year":"1984","unstructured":"Alpert A: Analysis of chlorophyll content in mosses through extraction in DMSO. The Bryologist. 1984, 87 (4): 363-365. 10.2307\/3242964.","journal-title":"The Bryologist"},{"key":"2765_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-422X-6-13","volume":"6","author":"AR Zekri","year":"2009","unstructured":"Zekri AR, Bahnassy AA, El-Din HM, Salama HM: Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J. 2009, 6: 13-10.1186\/1743-422X-6-13.","journal-title":"Virol J"},{"key":"2765_CR24","first-page":"4836","volume":"12","author":"MK El-Awady","year":"2006","unstructured":"El-Awady MK, Tabll AA, El-Abd YS, Bahgat MM, Shoeb HA, Youssef SS, NG B e-D, El RM R, El-Demellawy M, Omran MH, El-Garf WT, Goueli SA: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. World J Gastroenterol. 2006, 12: 4836-4842.","journal-title":"World J Gastroenterol"},{"key":"2765_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1086\/516792","volume":"195","author":"JA Hahn","year":"2007","unstructured":"Hahn JA: Sex, drugs and hepatitis C virus. J Infect Dis. 2007, 195: 1556-9. 10.1086\/516792.","journal-title":"J Infect Dis"},{"key":"2765_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1615\/CritRevImmunol.v30.i2.30","volume":"30","author":"L Rong","year":"2010","unstructured":"Rong L, Perelson AS: Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling. Crit Rev Immunol. 2010, 30: 131-148. 10.1615\/CritRevImmunol.v30.i2.30.","journal-title":"Crit Rev Immunol"},{"key":"2765_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1743-422X-8-16","volume":"8","author":"Inamullah","year":"2011","unstructured":"Inamullah , Idrees M, Ahmed H, Ghafoor S, Ali M, Ali L, Ahmed A: Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virol J. 2011, 8: 16-10.1186\/1743-422X-8-16.","journal-title":"Virol J"},{"key":"2765_CR28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1099\/0022-1317-78-10-2467","volume":"78","author":"SP Stefanie","year":"1997","unstructured":"Stefanie SP, Hubert MM, Eberhard P: Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol. 1997, 78: 2467-2476.","journal-title":"J Gen Virol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:24:11Z","timestamp":1630553051000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2765"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-247","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,17]]},"assertion":[{"value":"4 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"247"}}